[go: up one dir, main page]

CA2262267A1 - Anti-migraine pharmaceutical compositions and process of using - Google Patents

Anti-migraine pharmaceutical compositions and process of using Download PDF

Info

Publication number
CA2262267A1
CA2262267A1 CA 2262267 CA2262267A CA2262267A1 CA 2262267 A1 CA2262267 A1 CA 2262267A1 CA 2262267 CA2262267 CA 2262267 CA 2262267 A CA2262267 A CA 2262267A CA 2262267 A1 CA2262267 A1 CA 2262267A1
Authority
CA
Canada
Prior art keywords
pharmaceutical compositions
migraine
migraine pharmaceutical
tramadol
nsaid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2262267
Other languages
French (fr)
Other versions
CA2262267C (en
Inventor
Marc Raber
Helmut Momberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharma GmbH and Co KG
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Publication of CA2262267A1 publication Critical patent/CA2262267A1/en
Application granted granted Critical
Publication of CA2262267C publication Critical patent/CA2262267C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is an anti-migraine composition of a pharmacologically effective amount of both an antiemetic compound and of tramadol, and optionally of an NSAID, and a process for its anti-migraine use.
CA 2262267 1998-02-20 1999-02-19 Anti-migraine pharmaceutical compositions and process of using Expired - Fee Related CA2262267C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7533298P 1998-02-20 1998-02-20
US60/075,332 1998-02-20

Publications (2)

Publication Number Publication Date
CA2262267A1 true CA2262267A1 (en) 1999-08-20
CA2262267C CA2262267C (en) 2007-05-08

Family

ID=29581917

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2262267 Expired - Fee Related CA2262267C (en) 1998-02-20 1999-02-19 Anti-migraine pharmaceutical compositions and process of using

Country Status (1)

Country Link
CA (1) CA2262267C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009089494A2 (en) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Pharmaceutical compositions
EP1604658A3 (en) * 2001-04-10 2009-11-18 Reckitt Benckiser Healthcare (UK) Limited Pharmaceutical composition comprising ibuprofen and prochlorperazine
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
US8728522B2 (en) 2009-07-08 2014-05-20 Charleston Laboratories, Inc. Pharmaceutical compositions for treating or preventing pain
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1604658A3 (en) * 2001-04-10 2009-11-18 Reckitt Benckiser Healthcare (UK) Limited Pharmaceutical composition comprising ibuprofen and prochlorperazine
US9393207B2 (en) 2006-10-09 2016-07-19 Locl Pharma, Inc. Pharmaceutical compositions
US9427407B2 (en) 2006-10-09 2016-08-30 Locl Pharma, Inc. Pharmaceutical compositions
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
US9402813B2 (en) 2006-10-09 2016-08-02 Locl Pharma, Inc. Pharmaceutical compositions
US9399022B2 (en) 2006-10-09 2016-07-26 Locl Pharma, Inc. Pharmaceutical compositions
US9855264B2 (en) 2008-01-09 2018-01-02 Locl Pharma, Inc. Pharmaceutical compositions
US9775837B2 (en) 2008-01-09 2017-10-03 Charleston Laboratories, Inc. Pharmaceutical compositions
US9226901B2 (en) 2008-01-09 2016-01-05 Locl Pharma, Inc. Pharmaceutical compositions
US9198867B2 (en) 2008-01-09 2015-12-01 Charleston Laboratories, Inc. Pharmaceutical compositions
US10064856B2 (en) 2008-01-09 2018-09-04 Local Pharma, Inc. Pharmaceutical compositions
EP2240022A4 (en) * 2008-01-09 2012-04-25 Charleston Lab Inc PHARMACEUTICAL COMPOSITIONS
WO2009089494A2 (en) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Pharmaceutical compositions
US9498444B2 (en) 2008-01-09 2016-11-22 Locl Pharma, Inc. Pharmaceutical compositions
US9789104B2 (en) 2008-01-09 2017-10-17 Locl Pharma, Inc. Pharmaceutical compositions
US9387177B2 (en) 2008-01-09 2016-07-12 Locl Pharma, Inc. Pharmaceutical compositions
US9789105B2 (en) 2008-01-09 2017-10-17 Locl Pharma, Inc. Pharmaceutical compositions
US9526704B2 (en) 2009-07-08 2016-12-27 Locl Pharma, Inc. Pharmaceutical compositions for treating or preventing pain
US9433625B2 (en) 2009-07-08 2016-09-06 Locl Pharma, Inc. Pharmaceutical compositions for treating or preventing pain
US10016368B2 (en) 2009-07-08 2018-07-10 Locl Pharma, Inc. Pharmaceutical compositions for treating or preventing pain
US8728522B2 (en) 2009-07-08 2014-05-20 Charleston Laboratories, Inc. Pharmaceutical compositions for treating or preventing pain
US10532030B2 (en) 2009-07-08 2020-01-14 Locl Pharma, Inc. Pharmaceutical compositions for treating or preventing pain
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
US10772840B2 (en) 2016-03-04 2020-09-15 Charleston Laboratories, Inc. Sumatriptan promethazine pharmaceutical compositions

Also Published As

Publication number Publication date
CA2262267C (en) 2007-05-08

Similar Documents

Publication Publication Date Title
CA2333004A1 (en) Formoterol polymorphs
CA2278201A1 (en) Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene, and processes for their preparation
CA2163837A1 (en) Crystalline Paclitaxel Hydrates
CA2207323A1 (en) Use of pramipexole as a neuroprotective agent
EP1193270A3 (en) Pyrrolobenzodiazepines
CA2198599A1 (en) Salts of an Anti-Migraine Indole Derivative
AU2922295A (en) Use of 2-{(dihydro)pyrazolyl-3'-oxymethylene}-anilides as pest-control agents and fungicides
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
CA2315767A1 (en) Autoclavable pharmaceutical compositions containing a chelating agent
HK1041441A1 (en) Dispersible compositions containing l-dopa ethyl ester
CA2277274A1 (en) Crystal form 0 of clarithromycin
CA2213700A1 (en) Pharmaceutical composition for piperidinoalkanol compounds
CA2338600A1 (en) Novel thiazolopyrimidine compounds
CA2264097A1 (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
YU41199A (en) Quinoxalinediones
AU3841499A (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
AU1843397A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
CA2340224A1 (en) Nimesulide containing topical pharmaceutical compositions
AU672052B2 (en) Antidepressant and antiparkinsonian compounds
CA2149969A1 (en) Suspension concentrate compositions of arylpyrrole insecticidal and acaricidal agents
CA2352392A1 (en) Eletriptan hydrobromide monohydrate
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
CA2220019A1 (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
CA2262267A1 (en) Anti-migraine pharmaceutical compositions and process of using
CA2007261A1 (en) Novel tetralin derivatives

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180219